Study: HIV Patients Who Use Cannabis Daily See Lower Neuroinflammation
Marijuana Stocks, Finance, & InvestingUncategorized July 30, 2021 MJ Shareholders
HIV-positive patients who consume cannabis daily have lower levels of neuroinflammation than non-cannabis consuming HIV-positive patients, according to a University of California, San Diego study published this week in the Journal of the International Neuropsychological Society.
Researchers found that HIV-positive subjects who consumed cannabis daily possessed lower levels of chronic inflammation than did HIV-positive subjects who didn’t use cannabis and that the chronic inflammation results of those who used cannabis were similar to those of HIV-negative subjects with no history of cannabis use.
Read More
MJ Shareholders
MJShareholders.com is the largest dedicated financial network and leading corporate communications firm serving the legal cannabis industry. Our network aims to connect public marijuana companies with these focused cannabis audiences across the US and Canada that are critical for growth: Short and long term cannabis investors Active funding sources Mainstream media Business leaders Cannabis consumers
